News Articles for GenesisCare

Australians suffering hard-to-beat cancers are set to be the first to benefit from trials of new treatments conducted as part of a two-year partnership between Radiopharm Theranostics and GenesisCare. Tumours in the brain, lung and prostate will be targeted in three first-phase clinical trials in Australia, which will be aimed at studying the safety and tolerability of Radiopharm's novel radiopharmaceutical treatments.

GenesisCare and Icon Cancer Centre have been selected by the WA government to provide oncology services in Perth's greater metropolitan region, under a shared contract worth $21 million.

A common gout drug may prevent the progression of coronary disease, new research from Harry Perkins Institute of Medical Research and GenesisCare has found.

St John of God Health Care is partnering with GenesisCare and national medical property development group Heathley to deliver a $17 million comprehensive cancer centre at Murdoch.

National healthcare services provider GenesisCare has joined forces with the state government in a move that will more than double the treatment capacity for cancer patients in Western Australia over the next four years.